Targeting brain protein could halt progression of Alzheimer's

A protein that stimulates the brain to wake up could hold the key to preventative Alzheimer's treatments, an animal study suggests.

Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)
Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)

A mouse-model study conducted by US researchers suggests that targeting orexin, a neurotransmitter that helps rouse the brain from sleep, could help prevent Alzheimer’s disease in patients who have problems sleeping.

Sleep loss is known to contribute to the growth of brain plaques, early signs of Alzheimer’s disease.

They accumulate in the brain ahead of the onset of the more severe symptoms, such as memory loss. Scientists hope that by slowing or stopping this build-up, they can put a halt on the disease.

In the latest study, published in the Journal of Experimental Medicine, researchers bred genetically-modified mice lacking the gene for producing orexin with those predisposed to developing brain plaques.

Brain plaques halved

The offspring slept for longer and developed only half as many brain plaques as their predisposed parents who had the orexin protein, suggesting that higher levels of the neurotransmitter contribute to producing more brain plaques.

When the scientists reversed the experiment, and looked at mice with artificially increased orexin levels, the mice stayed awake longer and developed more Alzheimer's-like plaques.

Lead author Dr David Holtzman said: ‘This indicates we should be looking hard at orexin as a potential target for preventing Alzheimer’s disease.

‘Blocking orexin to increase sleep in patients with sleep abnormalities, or perhaps even to improve sleep efficiency in healthy people, may be a way to reduce the risk of Alzheimer's. This is important to explore further.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

BMA GP chair: 'GPs let down by tone deaf NHS demands on face-to-face appointments'

BMA GP chair: 'GPs let down by tone deaf NHS demands on face-to-face appointments'

NHS England has let down general practice with its 'tone deaf' demand for all patients...

GPs told to offer face-to-face appointments for all patients

GPs told to offer face-to-face appointments for all patients

GPs have condemned a 'blanket' demand from NHS England that all patients should be...

GP federation network seeks to boost primary care representation amid NHS reforms

GP federation network seeks to boost primary care representation amid NHS reforms

The NHS Confederation has set up a national network for GP federations in a bid to...

Sharp rise in GPs seeking mental health support during past year

Sharp rise in GPs seeking mental health support during past year

The number of GPs seeking help from NHS Practitioner Health, the specialist service...

Podcast: The GP workload crisis, mental wellbeing and vaccination success

Podcast: The GP workload crisis, mental wellbeing and vaccination success

In this episode of our new podcast Talking General Practice we look at the GP workload...

Long wait for COVID-19 public inquiry 'could drive doctors to quit NHS'

Long wait for COVID-19 public inquiry 'could drive doctors to quit NHS'

Doctors' leaders have criticised government plans to delay a public inquiry into...